Meb Puri-mega Liquid
NDC Package 81488-012-03
Package Information
Meb Puri-mega liquids is mEB Puri-Mega“Potent mineral concentrate with exceptional health benefits. This formulation utilizes a liquid delivery system. Marketed by Kadesh Incoporation Co,ltd, this product is identified by NDC 81488-012.
Identification & Billing
Clinical Specifications
- CALCIUM FLUORIDE 6 [hp_X]/300mL
- FERRIC CHLORIDE HEXAHYDRATE 7 [hp_X]/300mL
- FERROSOFERRIC PHOSPHATE 7 [hp_X]/300mL
- MAGNESIUM CHLORIDE 7 [hp_X]/300mL
- MAGNESIUM SULFATE HEPTAHYDRATE 7 [hp_X]/300mL
- PHOSPHORUS 6 [hp_X]/300mL
- SILICON DIOXIDE 4 [hp_X]/300mL
- SODIUM NITRATE 5 [hp_X]/300mL
- SULFUR 4 [hp_X]/300mL
- TITANIUM 7 [hp_X]/300mL
- ZINC 8 [hp_X]/300mL
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Iron - [CS]
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Parenteral Iron Replacement - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 81488 - Kadesh Incoporation Co,ltd
- 81488-012 - Meb Puri-mega
- 81488-012-03 - 300 mL in 1 BOTTLE
- 81488-012 - Meb Puri-mega
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (81488-012). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81488-012-03 identifies a specific commercial package of 300 ml in 1 bottle of Meb Puri-mega, a human over the counter drug labeled by Kadesh Incoporation Co,ltd. This liquid is formulated for oral use and contains calcium fluoride; ferric chloride hexahydrate; ferrosoferric phosphate; magnesium chloride; magnesium sulfate heptahydrate; phosphorus; silicon dioxide; sodium nitrate; sulfur; titanium; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kadesh Incoporation Co,ltd on August 18, 2023. The current certification is valid through December 31, 2026.
How is this Kadesh Incoporation Co,ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81488001203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.